Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Francesco PellegrinoArmando StabileGabriele SorceElio MazzoneDonato CannolettaGiuseppe Ottone CirulliLeonardo QuartaRiccardo LeniDaniele RobestiGiorgio BrembillaGiorgio GandagliaFrancesco De CobelliFrancesco MontorsiAlberto BrigantiPublished in: The Prostate (2023)
mpMRI PPV varies according to the individual pretest patient's risk based on clinical factors. These findings should be considered in the decision-making process for patients with suspect MRI findings referred for a prostate biopsy. Moreover, our data support the need for further studies to create an individualized risk prediction tool.